Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2017

May 11, 2017

32337_dirs_2017-05-11_a28af94a-84d2-4b73-a330-e8120538a2a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2017-05-09

Reporting Person: Aspauza Jossie (VP, SAM/CAM)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-09 Common Stock M 3600 $20.14 Acquired 5848 Direct
2017-05-09 Common Stock D 996 $72.81 Disposed 4852 Direct
2017-05-09 Common Stock F 782 $72.81 Disposed 4070 Direct
2017-05-09 Common Stock M 600 $21.57 Acquired 4670 Direct
2017-05-09 Common Stock D 178 $72.81 Disposed 4492 Direct
2017-05-09 Common Stock F 127 $72.81 Disposed 4365 Direct
2017-05-09 Common Stock M 1840 $6.82 Acquired 6205 Direct
2017-05-09 Common Stock D 173 $72.81 Disposed 6032 Direct
2017-05-09 Common Stock F 501 $72.81 Disposed 5531 Direct
2017-05-09 Common Stock M 1854 $22.94 Acquired 7385 Direct
2017-05-09 Common Stock D 585 $72.81 Disposed 6800 Direct
2017-05-09 Common Stock F 381 $72.81 Disposed 6419 Direct
2017-05-09 Common Stock M 2257 $53.29 Acquired 8676 Direct
2017-05-09 Common Stock D 1652 $72.81 Disposed 7024 Direct
2017-05-09 Common Stock F 182 $72.81 Disposed 6842 Direct
2017-05-09 Common Stock M 5409 $44.79 Acquired 12251 Direct
2017-05-09 Common Stock D 3328 $72.81 Disposed 8923 Direct
2017-05-09 Common Stock F 625 $72.81 Disposed 8298 Direct
2017-05-09 Common Stock M 453 $48.39 Acquired 8751 Direct
2017-05-09 Common Stock D 302 $72.81 Disposed 8449 Direct
2017-05-09 Common Stock F 46 $72.81 Disposed 8403 Direct
2017-05-09 Common Stock M 3914 $30.44 Acquired 12317 Direct
2017-05-09 Common Stock D 1638 $72.81 Disposed 10679 Direct
2017-05-09 Common Stock F 684 $72.81 Disposed 9995 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-09 Stock Appreciation Rights $20.14 M 3600 Disposed 2017-12-31 Common Stock (3600) Direct
2017-05-09 Stock Appreciation Rights $21.57 M 600 Disposed 2018-02-28 Common Stock (600) Direct
2017-05-09 Stock Appreciation Rights $6.82 M 1840 Disposed 2019-02-27 Common Stock (1840) Direct
2017-05-09 Stock Appreciation Rights $22.94 M 1854 Disposed 2020-05-07 Common Stock (1854) Direct
2017-05-09 Stock Appreciation Rights $53.29 M 2257 Disposed 2021-05-18 Common Stock (2257) Direct
2017-05-09 Stock Appreciation Rights $44.79 M 5409 Disposed 2022-05-31 Common Stock (5409) Direct
2017-05-09 Stock Appreciation Rights $48.39 M 453 Disposed 2022-09-01 Common Stock (453) Direct
2017-05-09 Stock Appreciation Rights $30.44 M 3914 Disposed 2025-03-02 Common Stock (3914) Direct

Footnotes

F1: The reporting person received 1,822 shares of common stock upon the net exercise of the 3,600 stock appreciation rights ("SARS"). The reporting person forfeited 996 shares of common stock underlying the SARS in payment of the exercise price and 782 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F2: The reporting person received 295 shares of common stock upon the net exercise of the 600 SARs. The reporting person forfeited 178 shares of common stock underlying the SARS in payment of the exercise price and 127 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F3: The reporting person received 1,166 shares of common stock upon the net exercise of the 1,840 SARs. The reporting person forfeited 173 shares of common stock underlying the SARS in payment of the exercise price and 501 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F4: The reporting person received 888 shares of common stock upon the net exercise of the 1,854 SARs. The reporting person forfeited 585 shares of common stock underlying the SARS in payment of the exercise price and 381 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F5: The reporting person received 423 shares of common stock upon the net exercise of the 2,257 SARs. The reporting person forfeited 1,652 shares of common stock underlying the SARS in payment of the exercise price and 182 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F6: The reporting person received 1,456 shares of common stock upon the net exercise of the 5,409 SARs. The reporting person forfeited 3,328 shares of common stock underlying the SARS in payment of the exercise price and 625 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F7: The reporting person received 105 shares of common stock upon the net exercise of the 453 SARS. The reporting person forfeited 302 shares of common stock underlying the SARS in payment of the exercise price and 46 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F8: The reporting person received 1,592 shares of common stock upon the net exercise of the 3,914 SARs. The reporting person forfeited 1,638 shares of common stock underlying the SARS in payment of the exercise price and 684 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

F9: Consists of 9,787 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.